The latest price and purchasing channels of Idecabtagene vicleucel in 2025

Idecabtagene vicleucel is an innovative immunotherapy designed to treat adult patients with relapsed or refractory multiple myeloma (MM). It is a genetically modified autologous T cell therapy guided by B cell maturation antigen (BCMA), which is designed to fight cancer through the patient's own immune system. Alkavilenza provides a new treatment option for these patients after at least two previous treatments, such as immunomodulators, proteasome inhibitors, and anti-CD38 monoclonal antibodies, have failed.

The core of this therapy is to use the patient's ownT cells for personalized treatment. First, T cells are extracted from the patient's blood and then genetically modified in the laboratory so that they can recognize and attack multiple myeloma cells. The modified T cells are infused back into the patient to enhance their ability to fight tumors. During the treatment process, the patient needs to first undergo 3 days of lymphocyte depletion chemotherapy to ensure that the body is more receptive to the transplanted cells, followed by intravenous infusion of Akivelense.

Because Elkavilenza is a highly specialized treatment, its infusion must be performed in a REMS (Risk Evaluation and Mitigation Strategy)-certified medical facility. This means that patients need to remain near the facility for at least 4 weeks after receiving treatment to allow for necessary monitoring and support. This measure aims to ensure that patients receive timely medical support during treatment and reduce potential side effects and complications. .

As of 2025Akvilenza has not yet been officially launched in China, so its specific price and medical insurance-related information are still unclear. However, depending on overseas markets, the cost of treatment with Akivelense is often very expensive and can reach hundreds of thousands of dollars. This is mainly due to its personalized treatment process and the requirement that it must be performed in a specific medical institution, which significantly increases the overall cost. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.

Reference materials:https://en.wikipedia.org/wiki/Idecabtagene_vicleucel